系统性红斑狼疮及免疫抑制剂对COVID-19疫苗接种抗体应答的影响
该研究基于Hopkins狼疮队列365次观察和1887名医护人员2235次观察,发现SLE患者接种COVID-19疫苗后IgG水平低于医护人员;接种后停用霉酚酸酯1周可显著提高疫苗IgG水平且未导致临床 flare;多变量模型显示霉酚酸酯、他克莫司和贝利尤单抗均显著降低抗体应答。
要点
- SLE患者接种COVID-19疫苗后IgG水平低于医护人员,无论是否使用免疫抑制剂。
- 接种后停用霉酚酸酯1周可显著提高疫苗IgG水平,且未导致临床 flare。
- 霉酚酸酯、他克莫司和贝利尤单抗在多变量模型中均显著降低疫苗抗体应答。
核心结论
- SLE患者无论背景免疫抑制治疗如何,疫苗IgG水平均低于医护人员。
- 霉酚酸酯、他克莫司和贝利尤单抗显著降低疫苗接种后IgG应答。
- 接种后停用霉酚酸酯1周可提高疫苗效力,带来疫苗应答的临床获益且未导致临床 flare。
研究设计与样本
- 在Hopkins狼疮队列中收集COVID-19感染、疫苗接种史和COVID-19抗体信息,并以医护人员队列作为对照。
- SLE队列分析基于334名不同患者的365次观察,医护人员队列基于1887名不同医护人员的2235次观察。
- 结局指标包括两个队列接种后随时间变化的SARS-CoV-2抗体IgG水平,以及SLE患者中免疫抑制药物对接种后IgG水平的影响。
主要发现
- 使用免疫抑制药物的SLE患者疫苗IgG水平低于未使用者,但两组均低于医护人员。
- 接种后停用霉酚酸酯1周显著提高疫苗后IgG水平,且未导致临床 flare。
- 在多变量模型中,霉酚酸酯、他克莫司和贝利尤单抗均显著降低疫苗接种抗体应答。
临床怎么用
- 作者报告接种后停用霉酚酸酯1周可提高疫苗效力,带来疫苗应答的临床获益且未导致临床 flare。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of COVID-19 infection is increased in patients with systemic lupus erythematosus (SLE) versus those without SLE. Some immunosuppressive medications increase COVID-19 infection and decrease the efficacy of vaccination. Consensus documents have suggested management strategies for handling immunosuppressive medications to increase vaccine efficacy, but the benefit of such strategies has not been proven. The current study was undertaken to determine the effect of immunosuppressive drugs on vaccine response in SLE. METHODS: We collected information on COVID-19 infection, vaccination history, and COVID-19 antibodies in the Hopkins Lupus Cohort. A cohort of health care workers was used for comparison. Outcome measures included SARS-CoV-2 antibody IgG levels after vaccination over time in both cohorts and effect of immunosuppressive medications on postvaccination IgG levels in SLE patients. RESULTS: The analysis was based on 365 observations from 334 different patients in the SLE cohort, and 2,235 observations from 1,887 different health care workers. SLE patients taking immunosuppressive medications had lower vaccine IgG levels than SLE patients who were not; but both groups had lower levels than health care workers. Holding mycophenolate for 1 week after vaccination increased postvaccine IgG levels significantly without leading to clinical flares. In multiple variable models, mycophenolate mofetil, tacrolimus, and belimumab all significantly reduced antibody response to vaccination. CONCLUSION: SLE patients, regardless of background immunosuppressive therapy, had lower vaccine IgG levels than health care workers. Mycophenolate, tacrolimus, and belimumab significantly reduced IgG response to vaccination. Holding mycophenolate for 1 week improved vaccine efficacy, providing clinical benefit on vaccine response without leading to clinical flares.
引用
- Petri M, Joyce D, Haag K, et al. Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID-19 Vaccination Antibody Response. Arthritis Care Res (Hoboken). 2023. PMID: 36714913. doi:10.1002/acr.25094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。